EY-Parthenon survey finds 54% of U.S. GLP-1 users take drugs for weight management and reports broad shopping and lifestyle changes

An EY-Parthenon GLP-1 consumer report reported Oct. 22, 2026, found 54% of U.S. GLP-1 users take the medication primarily for weight management and links use to shifts in shopping and lifestyle habits (Detroit NewsNetMedia; EY-Parthenon).

The research draws on multiple samples: EY-Parthenon’s third annual GLP-1 consumer survey was conducted between March and May 2026, and EY Studio+ ran an online survey in April 2026 that sampled 7,500 consumers globally (including 1,000 U.S. respondents) — EY documentation. Detroit NewsNetMedia’s coverage cites the larger study sample as 14,883 respondents overall with 3,602 current or former GLP-1 users. (Detroit NewsNetMedia; EY).

Report a correction · Editorial standards · Our source directory

BusinessIndy examines this development and its implications for Indiana businesses and communities using the linked sources.